GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kamphuis, Willem ^a   Mamber, Carlyn ^a   Moeton, Martina ^a   Kooijman, Lieneke ^a   Sluijs, Jacqueline A ^a   Jansen, Anne H P ^a   Verveer, Monique ^a   de Groot, Lody R ^a   Smith, Vanessa D ^a,c   Rangarajan, Sindhoo ^a   Rodríguez, José J ^d,e   Orre, Marie ^a   Hol, Elly M ^a,b  

^a ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Mayo Clinic   (United States)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN ALPHA; GLIAL FIBRILLARY ACIDIC PROTEIN BETA; GLIAL FIBRILLARY ACIDIC PROTEIN DELTA; GLIAL FIBRILLARY ACIDIC PROTEIN GAMMA; GLIAL FIBRILLARY ACIDIC PROTEIN KAPPA; GLIAL FIBRILLARY ACIDIC PROTEIN ZETA; NESTIN; UNCLASSIFIED DRUG; VIMENTIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN REGION; CONTROLLED STUDY; FEMALE; INTERMEDIATE FILAMENT; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; WILD TYPE;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIBODY SPECIFICITY; ASTROCYTES; BRAIN; DISEASE MODELS, ANIMAL; INTERMEDIATE FILAMENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGENESIS; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 84865056621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042823     Document Type: Article

References (81)

1. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35. 10.1007/s00401-009-0619-8 [doi].
2. Halassa MM, Haydon PG (2010) Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72: 335-355. 10.1146/annurev-physiol-021909-135843 [doi].
3. Seth P, Koul N, (2008) Astrocyte, the star avatar: redefined. J Biosci 33: 405-421.
4. Oberheim NA, Goldman SA, Nedergaard M (2012) Heterogeneity of astrocyte form and function. In: Walker JM, editors. Astrocytes. Methods and Protocols. Humana Press. 23-45.
5. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Varez-Buylla A, (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97: 703-716.
6. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, et al. (2008) Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31: 578-590.
7. Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, et al. (1998) Confocal observation of senile plaques in Alzheimer's disease: senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int 48: 332-340.
8. Middeldorp J, Hol EM (2011) GFAP in health and disease. Prog Neurobiol 93: 421-443. S0301-0082(11)00006-2 [pii];10.1016/j.pneurobio.2011.01.005 [doi].
9. Hyder CL, Isoniemi KO, Torvaldson ES, Eriksson JE (2011) Insights into intermediate filament regulation from development to ageing. J Cell Sci 124: 1363-1372. 124/9/1363 [pii];10.1242/jcs.041244 [doi].
10. Elobeid A, Bongcam-Rudloff E, Westermark B, Nister M (2000) AID-JNR14>3.0.CO;2-1 [pii].
11. Yoshida T, Tomozawa Y, Arisato T, Okamoto Y, Hirano H, et al. (2007) The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells. J Hum Genet 52: 362-369. 10.1007/s10038-007-0124-7 [doi].
12. Liem RK, Messing A (2009) Dysfunctions of neuronal and glial intermediate filaments in disease. J Clin Invest 119: 1814-1824. 38003 [pii];10.1172/JCI38003 [doi].
13. Bandyopadhyay U, Sridhar S, Kaushik S, Kiffin R, Cuervo AM (2010) Identification of regulators of chaperone-mediated autophagy. Mol Cell 39: 535-547. S1097-2765(10)00614-3 [pii];10.1016/j.molcel.2010.08.004 [doi].
14. Middeldorp J, Kamphuis W, Sluijs JA, Achoui D, Leenaars CH, et al. (2009) Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J 23: 2710-2726. fj.08-127696 [pii];10.1096/fj.08-127696 [doi].
15. Pekny M, Leveen P, Pekna M, Eliasson C, Berthold CH, et al. (1995) Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 14: 1590-1598.
16. Nawashiro H, Messing A, Azzam N, Brenner M, (1998) Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport 9: 1691-1696.
17. Nawashiro H, Brenner M, Fukui S, Shima K, Hallenbeck JM (2000) High susceptibility to cerebral ischemia in GFAP-null mice. J Cereb Blood Flow Metab 20: 1040-1044. 10.1097/00004647-200007000-00003 [doi].
18. Tanaka H, Katoh A, Oguro K, Shimazaki K, Gomi H, et al. (2002) Disturbance of hippocampal long-term potentiation after transient ischemia in GFAP deficient mice. J Neurosci Res 67: 11-20. 10.1002/jnr.10004 [pii].
19. Otani N, Nawashiro H, Fukui S, Ooigawa H, Ohsumi A, et al. (2006) Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice. J Clin Neurosci 13: 934-938.
20. Xu K, Malouf AT, Messing A, Silver J, (1999) Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia 25: 390-403.
21. Feinstein DL, Weinmaster GA, Milner RJ, (1992) Isolation of cDNA clones encoding rat glial fibrillary acidic protein: expression in astrocytes and in Schwann cells. J Neurosci Res 32: 1-14.
22. Condorelli DF, Nicoletti VG, Dell'Albani P, Barresi V, Caruso A, et al. (1999) GFAPbeta mRNA expression in the normal rat brain and after neuronal injury. Neurochem Res 24: 709-714.
23. Zelenika D, Grima B, Brenner M, Pessac B, (1995) A novel glial fibrillary acidic protein mRNA lacking exon 1. Brain Res Mol Brain Res 30: 251-258.
24. Hol EM, Roelofs RF, Moraal E, Sonnemans MA, Sluijs JA, et al. (2003) Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry 8: 786-796.
25. Roelofs RF, Fischer DF, Houtman SH, Sluijs JA, Van Haren W, et al. (2005) Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia 52: 289-300.
26. Blechingberg J, Holm IE, Nielsen KB, Jensen TH, Jorgensen AL, et al. (2007) Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform. Glia 55: 497-507.
27. Nielsen AL, Holm IE, Johansen M, Bonven B, Jorgensen P, et al. (2002) A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins. J Biol Chem 277: 29983-29991. 10.1074/jbc.M112121200 [doi];M112121200 [pii].
28. Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, et al. (2010) Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy. Epilepsy Res 90: 99-109. S0920-1211(10)00104-X [pii];10.1016/j.eplepsyres.2010.03.014 [doi].
29. Middeldorp J, van den Berge SA, Aronica E, Speijer D, Hol EM (2009) Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer. PLoS ONE 4: e7663. 10.1371/journal.pone.0007663 [doi].
30. Condorelli DF, Nicoletti VG, Barresi V, Conticello SG, Caruso A, et al. (1999) Structural features of the rat GFAP gene and identification of a novel alternative transcript. J Neurosci Res 56: 219-228.
31. Van den Berge SA, Middeldorp J, Zhang CE, Curtis MA, Leonard BW, et al. (2010) Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta. Aging Cell 9: 313-326. ACE556 [pii];10.1111/j.1474-9726.2010.00556.x [doi].
32. Andreiuolo F, Junier MP, Hol EM, Miquel C, Chimelli L, et al. (2008) GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneity. Neuropathology.
33. Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC (2009) Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor. Neurosci Lett 463: 182-187. S0304-3940(09)01026-X [pii];10.1016/j.neulet.2009.07.076 [doi].
34. Heo DH, Kim SH, Yang KM, Cho YJ, Kim KN, et al. (2012) A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-delta. J Neurooncol. 10.1007/s11060-012-0801-z [doi].
35. Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, et al. (2011) Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol 70: 69-82. 10.1097/NEN.0b013e318203ae74 [doi].
36. Marti-Fabregas J, Romaguera-Ros M, Gomez-Pinedo U, Martinez-Ramirez S, Jimenez-Xarrie E, et al. (2010) Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology 74: 357-365. WNL.0b013e3181cbccec [pii];10.1212/WNL.0b013e3181cbccec [doi].
37. Perng MD, Wen SF, Gibbon T, Middeldorp J, Sluijs J, et al. (2008) Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association. Mol Biol Cell 19: 4521-4533. E08-03-0284 [pii];10.1091/mbc.E08-03-0284 [doi].
38. Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM (2012) Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia 60: 615-629. 10.1002/glia.22295 [doi].
39. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170.
40. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM, (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24: 1063-1070.
41. Xue ZG, Cheraud Y, Brocheriou V, Izmiryan A, Titeux M, et al. (2004) The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res 298: 431-444. 10.1016/j.yexcr.2004.04.023 [doi];S0014482704002459 [pii].
42. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
43. Seri B, Garcia-Verdugo JM, Collado-Morente L, McEwen BS, Alvarez-Buylla A (2004) Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J Comp Neurol 478: 359-378. 10.1002/cne.20288 [doi].
44. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428. 10.1152/physrev.00027.2001 [doi].
45. Wong E, Cuervo AM (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol 2: a006734. cshperspect.a006734 [pii];10.1101/cshperspect.a006734 [doi].
46. Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49: 73-96. 10.1146/annurev.pharmtox.051208.165340 [doi].
47. Nielsen AL, Jorgensen AL (2004) Self-assembly of the cytoskeletal glial fibrillary acidic protein is inhibited by an isoform-specific C terminus. J Biol Chem 279: 41537-41545. 10.1074/jbc.M406601200 [doi];M406601200 [pii].
48. Westphal M, Lamszus K (2011) The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci 12: 495-508. nrn3060 [pii];10.1038/nrn3060 [doi].
49. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, et al. (2001) Intermediate filaments regulate astrocyte motility. J Neurochem 79: 617-625.
50. Kim S, Coulombe PA (2010) Emerging role for the cytoskeleton as an organizer and regulator of translation. Nat Rev Mol Cell Biol 11: 75-81. nrm2818 [pii];10.1038/nrm2818 [doi].
51. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16: 378-385. cdd2008172 [pii];10.1038/cdd.2008.172 [doi].
52. Kashon ML, Ross GW, O'Callaghan JP, Miller DB, Petrovitch H, et al. (2004) Associations of cortical astrogliosis with cognitive performance and dementia status. J Alzheimers Dis 6: 595-604.
53. Wharton SB, O'Callaghan JP, Savva GM, Nicoll JA, Matthews F, et al. (2009) Population Variation in Glial Fibrillary Acidic Protein Levels in Brain Ageing: Relationship to Alzheimer-Type Pathology and Dementia. Dement Geriatr Cogn Disord 27: 465-473. 000217729 [pii];10.1159/000217729 [doi].
54. Fuller S, Munch G, Steele M (2009) Activated astrocytes: a therapeutic target in Alzheimer's disease? Expert Rev Neurother 9: 1585-1594. 10.1586/ern.09.111 [doi].
55. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, et al. (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9: 453-457.
56. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S (2009) Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57: 978-988. 10.1002/glia.20822 [doi].
57. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ (2009) Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323: 1211-1215. 323/5918/1211 [pii];10.1126/science.1169096 [doi].
58. Peters O, Schipke CG, Philipps A, Haas B, Pannasch U, et al. (2009) Astrocyte Function is Modified by Alzheimer's Disease-like Pathology in Aged Mice. J Alzheimers Dis 18: 177-189. U7247X48G5108140 [pii];10.3233/JAD-2009-1140 [doi].
59. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, et al. (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30: 3326-3338. 30/9/3326 [pii];10.1523/JNEUROSCI.5098-09.2010 [doi].
60. Salmina AB (2009) Neuron-glia interactions as therapeutic targets in neurodegeneration. J Alzheimers Dis 16: 485-502. 70K75Q8784655437 [pii];10.3233/JAD-2009-0988 [doi].
61. Mei X, Ezan P, Giaume C, Koulakoff A (2010) Astroglial connexin immunoreactivity is specifically altered at beta-amyloid plaques in APP/PS1 mice. Neuroscience 171: 92-105. S0306-4522(10)01065-1 [pii];10.1016/j.neuroscience.2010.08.001 [doi].
62. Vincent AJ, Gasperini R, Foa L, Small DH (2010) Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity. J Alzheimers Dis 22: 699-714. 3P23585404211542 [pii];10.3233/JAD-2010-101089 [doi].
63. Muramori F, Kobayashi K, Nakamura I (1998) A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 52: 593-599. 10.1111/j.1440-1819.1998.tb02706.x [doi].
64. Noppe M, Crols R, Andries D, Lowenthal A (1986) Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin Chim Acta 155: 143-150. 0009-8981(86)90275-5 [pii].
65. Hanzel DK, Trojanowski JQ, Johnston RF, Loring JF (1999) High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner. Nat Biotechnol 17: 53-57. 10.1038/5225 [doi].
66. Vehmas AK, Kawas CH, Stewart WF, Troncoso JC (2003) Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging 24: 321-331. S0197458002000908 [pii].
67. Allaman I, Belanger M, Magistretti PJ (2011) Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34: 76-87. S0166-2236(10)00169-4 [pii];10.1016/j.tins.2010.12.001 [doi].
68. Buffo A, Rolando C, Ceruti S (2009) Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79: 77-89. S0006-2952(09)00768-0 [pii];10.1016/j.bcp.2009.09.014 [doi].
69. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647. S0166-2236(09)00153-2 [pii];10.1016/j.tins.2009.08.002 [doi].
70. Mastrangelo MA, Bowers WJ, (2008) Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci 9: 81.
71. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58: 831-838. 10.1002/glia.20967 [doi].
72. Lin RC, Matesic DF, Marvin M, McKay RD, Brustle O (1995) Re-expression of the intermediate filament nestin in reactive astrocytes. Neurobiol Dis 2: 79-85. S0969-9961(85)70008-3 [pii];10.1006/nbdi.1995.0008 [doi].
73. Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577. S0166-2236(97)01139-9 [pii].
74. Eng LF, Yu AC, Lee YL, (1992) Astrocytic response to injury. Prog Brain Res 94: 353-365.
75. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE, (1996) Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol 91: 269-277.
76. Yamada T, Kawamata T, Walker DG, McGeer PL, (1992) Vimentin immunoreactivity in normal and pathological human brain tissue. Acta Neuropathol 84: 157-162.
77. Rutka JT, Ivanchuk S, Mondal S, Taylor M, Sakai K, et al. (1999) Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neurosci 17: 503-515. S0736-5748(99)00049-0 [pii].
78. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, K, et al, (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
79. Dijk F, Kraal-Muller E, Kamphuis W, (2004) Ischemia-Induced Changes of AMPA-Type Glutamate Receptor Subunit Expression Pattern in the Rat Retina: A Real-Time Quantitative PCR Study. Invest Ophthalmol Vis Sci 45: 330-341.
80. Sarria AJ, Lieber JG, Nordeen SK, Evans RM, (1994) The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells. J Cell Sci 107 (Pt 6): 1593-1607.
81. Westermark B, Ponten J, Hugosson R, (1973) Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A 81: 791-805.